Prelude Therapeutics Incorporated logo
Prelude Therapeutics Incorporated PRLD
$ 1.3 46.4%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Prelude Therapeutics Incorporated Operating Income 2011-2024 | PRLD

Annual Operating Income Prelude Therapeutics Incorporated

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-132 M -124 M -114 M -58.8 M -28.1 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-28.1 M -132 M -91.3 M

Quarterly Operating Income Prelude Therapeutics Incorporated

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-34.4 M -37.2 M -34.3 M -33.4 M -32.4 M -29.1 M - -30.4 M -29.5 M -30.3 M - -30.8 M -27.9 M -22 M - -18.1 M -11.4 M -9.74 M - -6.88 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-6.88 M -37.2 M -26.1 M